Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vioplex-T versus placebo for pressure ulcer healing
2014-003121-17Phase 4Terminated
- Sponsor
- DAST Biotech
- Start
- Jul 2014
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in decubitus ulcer comparing Vioplex-T with Placebo (2 arms). Primary endpoint: Difference in pressure ulcer healing after 4 weeks. Started Jul 2014; status: terminated.
02
Drugs
neomycin + bacitracin
03
Conditions
decubitus ulcer
Beyond the preview
Go deeper on 2014-003121-17.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-003121-17.